顾客使用 Adooq 产品发表的高质量科研文献
Adooq用户使用VX-809 (Lumacaftor)发表的6篇文献
生物活性
| Discription | VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF). | ||
|---|---|---|---|
| Targets |
|
产品信息
| 目录号 | A10986 |
|---|---|
| 分子式 | C24H18F2N2O5 |
| 分子量 | 452.4 |
| CAS号 | 936727-05-8 |
| SMILES | CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O |
| 其他名称 | VX809 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
| In vitro (25°C) | DMSO | 88 mg/mL (194.51 mM) | |
| Water | Insoluble | ||
| Ethanol | 6 mg/mL (13.26 mM) | ||
| In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
Preparing Stock Solutions
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.1 mL | 110.52 mL | 221.04 mL |
| 0.5 mM | 4.42 mL | 22.1 mL | 44.21 mL |
| 1 mM | 2.21 mL | 11.05 mL | 22.1 mL |
| 5 mM | 0.44 mL | 2.21 mL | 4.42 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 VX-809 (Lumacaftor) | VX-809 (Lumacaftor) 供应商 | VX-809 (Lumacaftor) 花费 | VX-809 (Lumacaftor) 生产商 | 订购 VX-809 (Lumacaftor) | VX-809 (Lumacaftor) 代理商
| 购买 936727-05-8 | 936727-05-8 供应商 | 936727-05-8 花费 | 936727-05-8 生产商 | 订购 936727-05-8 | 936727-05-8 代理商

















